13.05.2022: The German Network against Antimicrobial Resistance (Deutsches Netzwerk gegen Antimikrobielle Resistenzen – DNAMR), which the Global AMR R&D Hub is a member of, just published a press release underlining the importance of a collaborative approach between research, development and the private sector when addressing AMR. Read more here.
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.